nodes	percent_of_prediction	percent_of_DWPC	metapath
Milnacipran—Breast disorder—Mercaptopurine—Crohn's disease	0.0167	0.0167	CcSEcCtD
Milnacipran—Delirium—Mesalazine—Crohn's disease	0.0161	0.0161	CcSEcCtD
Milnacipran—Proteinuria—Mesalazine—Crohn's disease	0.0158	0.0158	CcSEcCtD
Milnacipran—Protein urine present—Mesalazine—Crohn's disease	0.0156	0.0156	CcSEcCtD
Milnacipran—Cystitis noninfective—Mesalazine—Crohn's disease	0.0135	0.0135	CcSEcCtD
Milnacipran—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.0135	0.0135	CcSEcCtD
Milnacipran—Cystitis—Mesalazine—Crohn's disease	0.0134	0.0134	CcSEcCtD
Milnacipran—Dry eye—Mesalazine—Crohn's disease	0.0128	0.0128	CcSEcCtD
Milnacipran—Bladder pain—Mesalazine—Crohn's disease	0.0125	0.0125	CcSEcCtD
Milnacipran—Malnutrition—Mercaptopurine—Crohn's disease	0.0112	0.0112	CcSEcCtD
Milnacipran—Renal failure acute—Mesalazine—Crohn's disease	0.0109	0.0109	CcSEcCtD
Milnacipran—Libido decreased—Mesalazine—Crohn's disease	0.0108	0.0108	CcSEcCtD
Milnacipran—Thirst—Mesalazine—Crohn's disease	0.0106	0.0106	CcSEcCtD
Milnacipran—Suicidal ideation—Prednisone—Crohn's disease	0.0105	0.0105	CcSEcCtD
Milnacipran—Mania—Prednisone—Crohn's disease	0.0101	0.0101	CcSEcCtD
Milnacipran—Leukopenia—Mercaptopurine—Crohn's disease	0.00999	0.00999	CcSEcCtD
Milnacipran—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.00998	0.00998	CcSEcCtD
Milnacipran—Migraine—Mesalazine—Crohn's disease	0.0099	0.0099	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00944	0.00944	CcSEcCtD
Milnacipran—Liver function test abnormal—Mesalazine—Crohn's disease	0.00929	0.00929	CcSEcCtD
Milnacipran—Dry skin—Mesalazine—Crohn's disease	0.00922	0.00922	CcSEcCtD
Milnacipran—Breast disorder—Mesalazine—Crohn's disease	0.00909	0.00909	CcSEcCtD
Milnacipran—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00892	0.00892	CcSEcCtD
Milnacipran—Skin disorder—Mercaptopurine—Crohn's disease	0.00885	0.00885	CcSEcCtD
Milnacipran—Endocrine disorder—Prednisone—Crohn's disease	0.00884	0.00884	CcSEcCtD
Milnacipran—Abdominal distension—Mesalazine—Crohn's disease	0.00875	0.00875	CcSEcCtD
Milnacipran—Anorexia—Mercaptopurine—Crohn's disease	0.00868	0.00868	CcSEcCtD
Milnacipran—Delirium—Prednisone—Crohn's disease	0.00852	0.00852	CcSEcCtD
Milnacipran—Angina pectoris—Mesalazine—Crohn's disease	0.00847	0.00847	CcSEcCtD
Milnacipran—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.00844	0.00844	CcSEcCtD
Milnacipran—Contusion—Prednisone—Crohn's disease	0.0084	0.0084	CcSEcCtD
Milnacipran—Neutropenia—Mesalazine—Crohn's disease	0.00813	0.00813	CcSEcCtD
Milnacipran—Dysuria—Mesalazine—Crohn's disease	0.00813	0.00813	CcSEcCtD
Milnacipran—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00808	0.00808	CcSEcCtD
Milnacipran—Hepatobiliary disease—Azathioprine—Crohn's disease	0.00805	0.00805	CcSEcCtD
Milnacipran—Pollakiuria—Mesalazine—Crohn's disease	0.00803	0.00803	CcSEcCtD
Milnacipran—Decreased appetite—Mercaptopurine—Crohn's disease	0.00792	0.00792	CcSEcCtD
Milnacipran—Weight decreased—Mesalazine—Crohn's disease	0.00786	0.00786	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00786	0.00786	CcSEcCtD
Milnacipran—Hypercholesterolaemia—Prednisone—Crohn's disease	0.00775	0.00775	CcSEcCtD
Milnacipran—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.00768	0.00768	CcSEcCtD
Milnacipran—Urinary tract infection—Mesalazine—Crohn's disease	0.00753	0.00753	CcSEcCtD
Milnacipran—Haematuria—Mesalazine—Crohn's disease	0.00739	0.00739	CcSEcCtD
Milnacipran—Hepatobiliary disease—Mesalazine—Crohn's disease	0.00733	0.00733	CcSEcCtD
Milnacipran—Erythema multiforme—Azathioprine—Crohn's disease	0.00722	0.00722	CcSEcCtD
Milnacipran—Body temperature increased—Mercaptopurine—Crohn's disease	0.0072	0.0072	CcSEcCtD
Milnacipran—Hepatitis—Mesalazine—Crohn's disease	0.00696	0.00696	CcSEcCtD
Milnacipran—Mediastinal disorder—Azathioprine—Crohn's disease	0.00688	0.00688	CcSEcCtD
Milnacipran—Urinary tract disorder—Mesalazine—Crohn's disease	0.00687	0.00687	CcSEcCtD
Milnacipran—Oedema peripheral—Mesalazine—Crohn's disease	0.00685	0.00685	CcSEcCtD
Milnacipran—Chills—Azathioprine—Crohn's disease	0.00685	0.00685	CcSEcCtD
Milnacipran—Connective tissue disorder—Mesalazine—Crohn's disease	0.00684	0.00684	CcSEcCtD
Milnacipran—Urethral disorder—Mesalazine—Crohn's disease	0.00682	0.00682	CcSEcCtD
Milnacipran—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00671	0.00671	CcSEcCtD
Milnacipran—Erythema multiforme—Mesalazine—Crohn's disease	0.00658	0.00658	CcSEcCtD
Milnacipran—Eye disorder—Mesalazine—Crohn's disease	0.0065	0.0065	CcSEcCtD
Milnacipran—Cardiac disorder—Mesalazine—Crohn's disease	0.00646	0.00646	CcSEcCtD
Milnacipran—Angiopathy—Mesalazine—Crohn's disease	0.00631	0.00631	CcSEcCtD
Milnacipran—Mediastinal disorder—Mesalazine—Crohn's disease	0.00627	0.00627	CcSEcCtD
Milnacipran—Chills—Mesalazine—Crohn's disease	0.00624	0.00624	CcSEcCtD
Milnacipran—Diarrhoea—Mercaptopurine—Crohn's disease	0.00623	0.00623	CcSEcCtD
Milnacipran—Mental disorder—Mesalazine—Crohn's disease	0.0061	0.0061	CcSEcCtD
Milnacipran—Flatulence—Mesalazine—Crohn's disease	0.00597	0.00597	CcSEcCtD
Milnacipran—Leukopenia—Azathioprine—Crohn's disease	0.00595	0.00595	CcSEcCtD
Milnacipran—Tension—Mesalazine—Crohn's disease	0.00594	0.00594	CcSEcCtD
Milnacipran—Dysgeusia—Mesalazine—Crohn's disease	0.00593	0.00593	CcSEcCtD
Milnacipran—Vomiting—Mercaptopurine—Crohn's disease	0.00579	0.00579	CcSEcCtD
Milnacipran—Rash—Mercaptopurine—Crohn's disease	0.00574	0.00574	CcSEcCtD
Milnacipran—Dermatitis—Mercaptopurine—Crohn's disease	0.00574	0.00574	CcSEcCtD
Milnacipran—Vision blurred—Mesalazine—Crohn's disease	0.00571	0.00571	CcSEcCtD
Milnacipran—Tremor—Mesalazine—Crohn's disease	0.00567	0.00567	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00562	0.00562	CcSEcCtD
Milnacipran—Syncope—Mesalazine—Crohn's disease	0.00543	0.00543	CcSEcCtD
Milnacipran—Leukopenia—Mesalazine—Crohn's disease	0.00542	0.00542	CcSEcCtD
Milnacipran—Nausea—Mercaptopurine—Crohn's disease	0.00541	0.00541	CcSEcCtD
Milnacipran—Infection—Azathioprine—Crohn's disease	0.00539	0.00539	CcSEcCtD
Milnacipran—Palpitations—Mesalazine—Crohn's disease	0.00535	0.00535	CcSEcCtD
Milnacipran—Loss of consciousness—Mesalazine—Crohn's disease	0.00532	0.00532	CcSEcCtD
Milnacipran—Thrombocytopenia—Azathioprine—Crohn's disease	0.00531	0.00531	CcSEcCtD
Milnacipran—Skin disorder—Azathioprine—Crohn's disease	0.00527	0.00527	CcSEcCtD
Milnacipran—Hypertension—Mesalazine—Crohn's disease	0.00523	0.00523	CcSEcCtD
Milnacipran—Chest pain—Mesalazine—Crohn's disease	0.00516	0.00516	CcSEcCtD
Milnacipran—Anxiety—Mesalazine—Crohn's disease	0.00514	0.00514	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00512	0.00512	CcSEcCtD
Milnacipran—Irritability—Prednisone—Crohn's disease	0.00508	0.00508	CcSEcCtD
Milnacipran—Hypotension—Azathioprine—Crohn's disease	0.00507	0.00507	CcSEcCtD
Milnacipran—Dry mouth—Mesalazine—Crohn's disease	0.00504	0.00504	CcSEcCtD
Milnacipran—Infection—Mesalazine—Crohn's disease	0.00491	0.00491	CcSEcCtD
Milnacipran—Dry skin—Prednisone—Crohn's disease	0.00488	0.00488	CcSEcCtD
Milnacipran—Shock—Mesalazine—Crohn's disease	0.00486	0.00486	CcSEcCtD
Milnacipran—Nervous system disorder—Mesalazine—Crohn's disease	0.00485	0.00485	CcSEcCtD
Milnacipran—Thrombocytopenia—Mesalazine—Crohn's disease	0.00484	0.00484	CcSEcCtD
Milnacipran—Tachycardia—Mesalazine—Crohn's disease	0.00482	0.00482	CcSEcCtD
Milnacipran—Skin disorder—Mesalazine—Crohn's disease	0.0048	0.0048	CcSEcCtD
Milnacipran—Hyperhidrosis—Mesalazine—Crohn's disease	0.00478	0.00478	CcSEcCtD
Milnacipran—Anorexia—Mesalazine—Crohn's disease	0.00471	0.00471	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00469	0.00469	CcSEcCtD
Milnacipran—Abdominal distension—Prednisone—Crohn's disease	0.00463	0.00463	CcSEcCtD
Milnacipran—Hypotension—Mesalazine—Crohn's disease	0.00462	0.00462	CcSEcCtD
Milnacipran—Insomnia—Mesalazine—Crohn's disease	0.00447	0.00447	CcSEcCtD
Milnacipran—Paraesthesia—Mesalazine—Crohn's disease	0.00444	0.00444	CcSEcCtD
Milnacipran—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00444	0.00444	CcSEcCtD
Milnacipran—Dyspnoea—Mesalazine—Crohn's disease	0.00441	0.00441	CcSEcCtD
Milnacipran—Somnolence—Mesalazine—Crohn's disease	0.00439	0.00439	CcSEcCtD
Milnacipran—Dyspepsia—Mesalazine—Crohn's disease	0.00435	0.00435	CcSEcCtD
Milnacipran—Neutropenia—Prednisone—Crohn's disease	0.0043	0.0043	CcSEcCtD
Milnacipran—Decreased appetite—Mesalazine—Crohn's disease	0.0043	0.0043	CcSEcCtD
Milnacipran—Abdominal pain—Azathioprine—Crohn's disease	0.00429	0.00429	CcSEcCtD
Milnacipran—Body temperature increased—Azathioprine—Crohn's disease	0.00429	0.00429	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00427	0.00427	CcSEcCtD
Milnacipran—Fatigue—Mesalazine—Crohn's disease	0.00426	0.00426	CcSEcCtD
Milnacipran—Erectile dysfunction—Prednisone—Crohn's disease	0.00424	0.00424	CcSEcCtD
Milnacipran—Constipation—Mesalazine—Crohn's disease	0.00423	0.00423	CcSEcCtD
Milnacipran—Weight decreased—Prednisone—Crohn's disease	0.00416	0.00416	CcSEcCtD
Milnacipran—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00404	0.00404	CcSEcCtD
Milnacipran—Hypersensitivity—Azathioprine—Crohn's disease	0.004	0.004	CcSEcCtD
Milnacipran—Urticaria—Mesalazine—Crohn's disease	0.00393	0.00393	CcSEcCtD
Milnacipran—Body temperature increased—Mesalazine—Crohn's disease	0.00391	0.00391	CcSEcCtD
Milnacipran—Abdominal pain—Mesalazine—Crohn's disease	0.00391	0.00391	CcSEcCtD
Milnacipran—Diarrhoea—Azathioprine—Crohn's disease	0.00371	0.00371	CcSEcCtD
Milnacipran—Hallucination—Prednisone—Crohn's disease	0.00366	0.00366	CcSEcCtD
Milnacipran—Hypersensitivity—Mesalazine—Crohn's disease	0.00364	0.00364	CcSEcCtD
Milnacipran—Connective tissue disorder—Prednisone—Crohn's disease	0.00362	0.00362	CcSEcCtD
Milnacipran—Dizziness—Azathioprine—Crohn's disease	0.00359	0.00359	CcSEcCtD
Milnacipran—Asthenia—Mesalazine—Crohn's disease	0.00355	0.00355	CcSEcCtD
Milnacipran—Pruritus—Mesalazine—Crohn's disease	0.0035	0.0035	CcSEcCtD
Milnacipran—Vomiting—Azathioprine—Crohn's disease	0.00345	0.00345	CcSEcCtD
Milnacipran—Eye disorder—Prednisone—Crohn's disease	0.00344	0.00344	CcSEcCtD
Milnacipran—Rash—Azathioprine—Crohn's disease	0.00342	0.00342	CcSEcCtD
Milnacipran—Dermatitis—Azathioprine—Crohn's disease	0.00342	0.00342	CcSEcCtD
Milnacipran—Flushing—Prednisone—Crohn's disease	0.00342	0.00342	CcSEcCtD
Milnacipran—Headache—Azathioprine—Crohn's disease	0.0034	0.0034	CcSEcCtD
Milnacipran—Diarrhoea—Mesalazine—Crohn's disease	0.00338	0.00338	CcSEcCtD
Milnacipran—Angiopathy—Prednisone—Crohn's disease	0.00334	0.00334	CcSEcCtD
Milnacipran—Dizziness—Mesalazine—Crohn's disease	0.00327	0.00327	CcSEcCtD
Milnacipran—Mental disorder—Prednisone—Crohn's disease	0.00323	0.00323	CcSEcCtD
Milnacipran—Nausea—Azathioprine—Crohn's disease	0.00322	0.00322	CcSEcCtD
Milnacipran—Malnutrition—Prednisone—Crohn's disease	0.0032	0.0032	CcSEcCtD
Milnacipran—Vomiting—Mesalazine—Crohn's disease	0.00314	0.00314	CcSEcCtD
Milnacipran—Rash—Mesalazine—Crohn's disease	0.00312	0.00312	CcSEcCtD
Milnacipran—Dermatitis—Mesalazine—Crohn's disease	0.00311	0.00311	CcSEcCtD
Milnacipran—Headache—Mesalazine—Crohn's disease	0.0031	0.0031	CcSEcCtD
Milnacipran—Vision blurred—Prednisone—Crohn's disease	0.00302	0.00302	CcSEcCtD
Milnacipran—Agitation—Prednisone—Crohn's disease	0.00295	0.00295	CcSEcCtD
Milnacipran—Nausea—Mesalazine—Crohn's disease	0.00294	0.00294	CcSEcCtD
Milnacipran—Syncope—Prednisone—Crohn's disease	0.00287	0.00287	CcSEcCtD
Milnacipran—Loss of consciousness—Prednisone—Crohn's disease	0.00282	0.00282	CcSEcCtD
Milnacipran—Convulsion—Prednisone—Crohn's disease	0.00278	0.00278	CcSEcCtD
Milnacipran—Hypertension—Prednisone—Crohn's disease	0.00277	0.00277	CcSEcCtD
Milnacipran—Anxiety—Prednisone—Crohn's disease	0.00272	0.00272	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00271	0.00271	CcSEcCtD
Milnacipran—Infection—Prednisone—Crohn's disease	0.0026	0.0026	CcSEcCtD
Milnacipran—Shock—Prednisone—Crohn's disease	0.00257	0.00257	CcSEcCtD
Milnacipran—Nervous system disorder—Prednisone—Crohn's disease	0.00256	0.00256	CcSEcCtD
Milnacipran—Tachycardia—Prednisone—Crohn's disease	0.00255	0.00255	CcSEcCtD
Milnacipran—Skin disorder—Prednisone—Crohn's disease	0.00254	0.00254	CcSEcCtD
Milnacipran—Hyperhidrosis—Prednisone—Crohn's disease	0.00253	0.00253	CcSEcCtD
Milnacipran—Anorexia—Prednisone—Crohn's disease	0.00249	0.00249	CcSEcCtD
Milnacipran—Insomnia—Prednisone—Crohn's disease	0.00237	0.00237	CcSEcCtD
Milnacipran—Paraesthesia—Prednisone—Crohn's disease	0.00235	0.00235	CcSEcCtD
Milnacipran—Dyspepsia—Prednisone—Crohn's disease	0.0023	0.0023	CcSEcCtD
Milnacipran—Decreased appetite—Prednisone—Crohn's disease	0.00227	0.00227	CcSEcCtD
Milnacipran—Fatigue—Prednisone—Crohn's disease	0.00225	0.00225	CcSEcCtD
Milnacipran—Constipation—Prednisone—Crohn's disease	0.00224	0.00224	CcSEcCtD
Milnacipran—Gastrointestinal pain—Prednisone—Crohn's disease	0.00214	0.00214	CcSEcCtD
Milnacipran—Urticaria—Prednisone—Crohn's disease	0.00208	0.00208	CcSEcCtD
Milnacipran—Abdominal pain—Prednisone—Crohn's disease	0.00207	0.00207	CcSEcCtD
Milnacipran—Body temperature increased—Prednisone—Crohn's disease	0.00207	0.00207	CcSEcCtD
Milnacipran—Hypersensitivity—Prednisone—Crohn's disease	0.00193	0.00193	CcSEcCtD
Milnacipran—Asthenia—Prednisone—Crohn's disease	0.00188	0.00188	CcSEcCtD
Milnacipran—Pruritus—Prednisone—Crohn's disease	0.00185	0.00185	CcSEcCtD
Milnacipran—Diarrhoea—Prednisone—Crohn's disease	0.00179	0.00179	CcSEcCtD
Milnacipran—Dizziness—Prednisone—Crohn's disease	0.00173	0.00173	CcSEcCtD
Milnacipran—Vomiting—Prednisone—Crohn's disease	0.00166	0.00166	CcSEcCtD
Milnacipran—Rash—Prednisone—Crohn's disease	0.00165	0.00165	CcSEcCtD
Milnacipran—Dermatitis—Prednisone—Crohn's disease	0.00165	0.00165	CcSEcCtD
Milnacipran—Headache—Prednisone—Crohn's disease	0.00164	0.00164	CcSEcCtD
Milnacipran—Nausea—Prednisone—Crohn's disease	0.00155	0.00155	CcSEcCtD
